In vivo molecular imaging of apoptosisand necrosis in atherosclerotic plaquesusing MicroSPECT-CT and MicroPET-CT Imaging

Molecular Imaging and Biology

Volumn 16, Issue 2, 2014, Pages 246-254

  De Saint Hubert, M ^a,b   Bauwens, M ^a   Deckers, N ^c   Drummen, M ^a   Douma, K ^a,b   Granton, P ^d   Hendrikx, G ^a,b   Kusters, D ^c   Bucerius, J ^a,b,e   Reutelingsperger, C P M ^c   Mottaghy, F M ^a,e  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d MAASTRO CLINIC   (Netherlands)

^e UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Apoptosis; Atherosclerosis; Molecular imaging; Necrosis

Indexed keywords

ANNEXIN A5 TC 99M; HYPERICIN I 124; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CAROTID ATHEROSCLEROSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; MOLECULAR IMAGING; MOUSE; MULTIMODAL IMAGING; NECROSIS; NONHUMAN; PLASMA CLEARANCE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

MUS;

ANIMALS; ANNEXIN A5; APOPTOSIS; HUMANS; MICE; MOLECULAR IMAGING; MULTIMODAL IMAGING; NECROSIS; PERYLENE; PLAQUE, ATHEROSCLEROTIC; POSITRON-EMISSION TOMOGRAPHY; TECHNETIUM; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84896404132     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-013-0677-0     Document Type: Article

References (33)

1. Bui QT, Prempeh M, Wilensky RL (2009) Atherosclerotic plaque development. Int J Biochem Cell Biol 41(11):2109-2113
2. Kolodgie FD, Petrov A, Virmani R et al (2003) Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque. Circulation 108:3134-3139
3. Kietselaer BL, Reutelingsperger CP, Heidendal GA et al (2004) Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. N Engl J Med 350:1472-1473
4. 99mTc-annexin V. J Nucl Med 46(5):807-815
5. 68Ga-labeled Annexin A5 as a PET imaging agent for apoptosis. Nucl Med Biol 38:381-392
6. 99mTc(CO)3 for improved imaging of apoptosis in vivo. Bioorg Med Chem 18:1356-1363
7. 68Ga-Cys2-AnxA5 for molecular imaging of apoptosis. Q J Nucl Med Mol Imaging 57:187-200
8. De Saint-Hubert M, Wang H, Devos E et al (2010) Preclinical imaging of therapy response using metabolic and apoptosis molecular imaging. Mol Imaging Biol 13:995-1002
9. 99mTc-labeled HYNIC-cys-annexin A5 as an apoptosis imaging agent. Bioorg Med Chem Lett 18:3794-3798
10. Tait JF, Smith C, Levashova Z et al (2006) Improved detection of cell death in vivo with annexin V radiolabeled by site-specific methods. J Nucl Med 47:1546-1553
11. Galluzzi L, Vitale I, Abrams JM et al (2011) Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ 19:107-120
12. Martinet W, Schrijvers DM, De Meyer GR (2011) Necrotic cell death in atherosclerosis. Basic Res Cardiol 106:749-760
13. De Saint-Hubert M, Prinsen K et al (2009) Molecular imaging of cell death. Methods 48(2):178-187
14. 123)I]iodohypericin and mono-[(123)I]iodoprotohypericin in a mouse model with a RIF-1 tumor. Contrast Media Mol Imaging 2:113-119
15. Van de Putte M, Marysael T, Fonge H et al (2011) Radiolabeled iodohypericin as tumor necrosis avid tracer: diagnostic and therapeutic potential. Int J Cancer 131:E129-E137
16. von der Thusen JH, van Berkel TJ, Biessen EA (2001) Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice. Circulation 103:1164-1170
17. Ku DN, Giddens DP, Zarins CK, Glagov S (1985) Pulsatile flow and atherosclerosis in the human carotid bifurcation. Positive correlation between plaque location and low oscillating shear stress. Arteriosclerosis 5:293-302
18. Topper JN, Gimbrone MA Jr (1999) Blood flow and vascular gene expression: fluid shear stress as a modulator of endothelial phenotype. Mol Med Today 5:40-46
19. Golledge J, Turner RJ, Harley SL et al (1997) Circumferential deformation and shear stress induce differential responses in saphenous vein endothelium exposed to arterial flow. J Clin Invest 99:2719-2726
20. Nakashima Y, Plump AS, Raines EW et al (1994) ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 14:133-140
21. Lievens D, Gerdes N, Schober A, Weber C (2010) Atherosclerosis: cell biology and lipoproteins. Curr Opin Lipidol 21:284-285
22. Lievens D, Zernecke A, Seijkens T et al (2010) Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis. Blood 116:4317-4327
23. Thorp E, Li G, Seimon TA et al (2009) Reduced apoptosis and plaque necrosis in advanced atherosclerotic lesions of Apoe-/- and Ldlr-/- mice lacking CHOP. Cell Metab 9:474-481
24. Isobe S, Tsimikas S, Zhou J et al (2006) Noninvasive imaging of atherosclerotic lesions in apolipoprotein E-deficient and low-density- lipoprotein receptor-deficient mice with annexin A5. J Nucl Med 47:1497-1505
25. 99mTc-annexin A5 uptake in apolipoprotein E-deficient and wild-type C57BL/6J mice. J Nucl Med 49:1707-1714
26. van Tilborg GA, Vucic E, Strijkers GJ et al (2010) Annexin A5-functionalized bimodal nanoparticles for MRI and fluorescence imaging of atherosclerotic plaques. Bioconjug Chem 21:1794-1803
27. Ding SF, Ni M, Liu XL et al (2010) A causal relationship between shear stress and atherosclerotic lesions in apolipoprotein E knockout mice assessed by ultrasound biomicroscopy. Am J Physiol Heart Circ Physiol 298:H2121-H2129
28. Kenis H, Zandbergen HR, Hofstra L et al (2010) Annexin A5 uptake in ischemic myocardium: demonstration of reversible phosphatidylserine externalization and feasibility of radionuclide imaging. J Nucl Med 51:259-267
29. Hartung D, Sarai M, Petrov A et al (2005) Resolution of apoptosis in atherosclerotic plaque by dietary modification and statin therapy. J Nucl Med 46:2051-2056
30. Bormans G, Huyghe D, Christiaen A et al (2004) Preparation, analysis and biodistribution in mice of iodine-123 labelled derivatives of hypericin. J Label Compd Radiopharm 47:191-198
31. Lavie G, Mazur Y, Lavie D, Meruelo D (1995) The chemical and biological properties of hypericin - a compound with a broad spectrum of biological activities. Med Res Rev 15:111-119
32. 68Ga labeled pamoic acid derivative for in vivo visualization of necrosis using positron emission tomography. Bioorg Med Chem 18:5274-5281
33. Phinikaridou A, Andia ME, Shah AM, Botnar RM (2012) Advances in molecular imaging of atherosclerosis and myocardial infarction: shedding new light on in vivo cardiovascular biology. Am J Physiol Heart Circ Physiol 303:H1397-H1410